Jonathan Schwartz
2018
In 2018, Jonathan Schwartz earned a total compensation of $1.4M as Chief Medical Officer and SVP, Clinical Development at Inotek Pharmaceuticals.
Compensation breakdown
| Bonus | $157,241 |
|---|---|
| Option Awards | $830,761 |
| Salary | $359,820 |
| Other | $8,854 |
| Total | $1,356,676 |
Schwartz received $830.8K in option awards, accounting for 61% of the total pay in 2018.
Schwartz also received $157.2K in bonus, $359.8K in salary and $8.9K in other compensation.
Rankings
In 2018, Jonathan Schwartz's compensation ranked 7,655th out of 14,244 executives tracked by ExecPay. In other words, Schwartz earned more than 46.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,655 out of 14,244 | 46th |
Division Manufacturing | 2,975 out of 5,765 | 48th |
Major group Chemicals And Allied Products | 1,115 out of 2,128 | 48th |
Industry group Drugs | 943 out of 1,817 | 48th |
Industry Pharmaceutical Preparations | 735 out of 1,391 | 47th |
Source: SEC filing on April 30, 2019.
Schwartz's colleagues
We found three more compensation records of executives who worked with Jonathan Schwartz at Inotek Pharmaceuticals in 2018.